This study can help to understand the underlying molecular mechanism by which SLC26A9 upregulation in human CRC promotes neoplasm initiation and progression by activating the Wnt/β-catenin signaling pathway. The gene discussed is SLC26A9; the disease is colorectal carcinoma.